About AGI Dermatics
AGI Dermatics is a company based in Freeport (United States) founded in 1985 was acquired by Estee Lauder Companies in September 2008.. AGI Dermatics has raised $10.5 million across 2 funding rounds from investors including Estee Lauder Companies, Trevi Health Ventures and Spring Mountain Capital. AGI Dermatics operates in a competitive market with competitors including GSK, Avidity Biosciences, Sutro Biopharma, Antheia and Vividion Therapeutics, among others.
- Headquarter Freeport, United States
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Agi Dermatics Inc
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$10.5 M (USD)
in 2 rounds
-
Latest Funding Round
$5 M (USD), Series B
Apr 08, 2008
-
Investors
Estee Lauder Companies
& 2 more
-
Employee Count
Employee Count
-
Acquired by
Estee Lauder Companies
(Sep 30, 2008)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of AGI Dermatics
AGI Dermatics has successfully raised a total of $10.5M across 2 strategic funding rounds. The most recent funding activity was a Series B round of $5 million completed in April 2008. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 2
- Last Round Series B — $5.0M
-
First Round
First Round
(09 Oct 2006)
- Investors Count 2
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Apr, 2008 | Amount | Series B - AGI Dermatics | Valuation | Trevi Health Ventures , Spring Mountain Capital |
|
| Oct, 2006 | Amount | Series A - AGI Dermatics | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in AGI Dermatics
AGI Dermatics has secured backing from 3 investors, including venture fund and institutional investors. Prominent investors backing the company include Estee Lauder Companies, Trevi Health Ventures and Spring Mountain Capital. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Founded Year | Domain | Location | |
|
Venture capital fund focused on multiple sectors
|
Founded Year | Domain | Location | |
|
Luxury cosmetics and beauty products are manufactured and distributed worldwide.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by AGI Dermatics
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - AGI Dermatics
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Agi Dermatics Comparisons
Competitors of AGI Dermatics
AGI Dermatics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as GSK, Avidity Biosciences, Sutro Biopharma, Antheia and Vividion Therapeutics, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Developer of pharmaceuticals and vaccines for various therapeutic areas
|
|
| domain | founded_year | HQ Location |
Antibody-siRNA complexes are developed for cancer treatment.
|
|
| domain | founded_year | HQ Location |
Antibody-based therapeutics for cancer therapy are developed via cell-free synthesis.
|
|
| domain | founded_year | HQ Location |
Yeast cells are genetically engineered to produce medicinal products.
|
|
| domain | founded_year | HQ Location |
Developing novel drugs based on a proteome-wide ligand and target discovery platform
|
|
| domain | founded_year | HQ Location |
CRISPR-engineered cell and gene therapies are developed for research applications.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about AGI Dermatics
When was AGI Dermatics founded?
AGI Dermatics was founded in 1985 and raised its 1st funding round 21 years after it was founded.
Where is AGI Dermatics located?
AGI Dermatics is headquartered in Freeport, United States.
Is AGI Dermatics a funded company?
AGI Dermatics is a funded company, having raised a total of $10.5M across 2 funding rounds to date. The company's 1st funding round was a Series A of $5.5M, raised on Oct 09, 2006.
What does AGI Dermatics do?
Founded in 1985 in Freeport, United States, AGI Dermatics operates in the biotechnology sector with a focus on dermatology. Research is conducted on DNA repair processes, solar effects on the immune system, and skin cell signaling pathways. L-Ergothioneine is identified as a compound that suppresses MMP1 secretion to reduce photodamage from oxidative stress. The product Remergent, formulated with L-Ergothioneine, is delivered using liposome technology for skin applications.
Who are the top competitors of AGI Dermatics?
AGI Dermatics's top competitors include Sutro Biopharma, Synthego and Avidity Biosciences.
Who are AGI Dermatics's investors?
AGI Dermatics has 3 investors. Key investors include Estee Lauder Companies, Trevi Health Ventures, and Spring Mountain Capital.